SCIESCOPUSQ1
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
MOSBY-ELSEVIER, United States
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY is an academic journal published by MOSBY-ELSEVIER (United States). Identifiers: ISSN 0091-6749, eISSN 1097-6825. Indexed in SCIE, SCOPUS. Metrics: JIF 11.2, CiteScore 21.7, SJR 3.935, SNIP 2.56. Subject areas: ALLERGY, IMMUNOLOGY. tlooto lists 5,968 papers from this journal.
CiteScore
21.70
Scopus citation metric
SJR
3.935
SCImago rank
SNIP
2.56
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 0091-6749
- eISSN
- 1097-6825
- Abbreviation
- J ALLERGY CLIN IMMUN
- Publisher
- MOSBY-ELSEVIER
- Country
- United States
Web of Science categories
SCIEALLERGY, IMMUNOLOGY
Scopus ASJC categories
2403 Immunology2723 Immunology and Allergy
Keywords
Allergy | Immunology
Papers in this journal
Recent papers
- On-demand Treatment Patterns of Hereditary Angioedema (HAE) Attacks with Sebetralstat in the KONFIDENT-S Study
2026
- IRF1 is a master regulator of type 1 eosinophils.
2026
- A Novel Panel of Autoantibodies May Assist In The Molecular Diagnosis Of CSU
2026
- Head-to-Head Comparison of Topical and Oral Heat-Killed Lactobacillus plantarum (Immuno-LP20) Demonstrates Superior Topical Efficacy in an Atopic Dermatitis Mouse Model
2026
- Epigenetic gestational age acceleration in cord blood is associated with activated inflammatory gene pathways and childhood asthma.
2026
Most cited papers
- Comparative efficacy and safety of biologics and systemic immunomodulatory treatments for chronic urticaria: Systematic review and network meta-analysis
2025 · 25 citations
- Dupilumab Significantly Reduces Itch and Hives in Patients With Chronic Spontaneous Urticaria: Results From a Phase 3 Trial (LIBERTY-CSU CUPID Study A)
2022 · 24 citations
- Analysis of airway inflammation demonstrates a mechanism for T2-biologic failure in asthma
2025 · 24 citations
- Barzolvolimab Significantly Decreases Chronic Spontaneous Urticaria Disease Activity and is Well Tolerated: Top Line Results from a Phase 2 Trial
2024 · 21 citations
- S aureus upregulation of MUC13 modulates mucosal remodeling in chronic rhinosinusitis via MEK1/2 and WNT2B
2025 · 20 citations